文献速递妇科

hsa-miR-124、SOX1、TERT和LMX1A基因甲基化作为宫颈癌前病变生物标志物

Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
PubMed 文献 · Gynecol Oncol · 2018-06-28

研究纳入447例接受阴道镜检查女性的宫颈细胞学样本,按CIN分级分为无CIN组152例、CIN1组147例和CIN2/3组148例,用qMSP分析15个基因甲基化。结果显示hsa-miR-124基因甲基化敏感度86.7%、特异度61.3%,与HPV检测的91.3%和50.0%相似,hsa-miR-124-2、SOX1、TERT和LMX1A基因高甲基化可能是宫颈癌前病变的有前景生物标志物。

要点

  • hsa-miR-124甲基化敏感度86.7%、特异度61.3%,与HPV检测的91.3%和50.0%相似
  • 与CIN2+诊断独立相关的因素包括hr-HPV阳性(OR=5.5)及hsa-miR-124-2(OR=5.1)、SOX1(OR=2.8)、TERT(OR=2.2)、LMX1A(OR=2.0)基因甲基化
  • hsa-miR-124-2、SOX1、TERT和LMX1A基因高甲基化可能是宫颈癌前病变的有前景生物标志物,无论hr-HPV状态如何

核心结论

  • hsa-miR-124-2、SOX1、TERT和LMX1A基因高甲基化可能是宫颈癌前病变的有前景生物标志物,无论hr-HPV状态如何。

研究设计与样本

  • 共检查447例接受阴道镜检查女性的宫颈细胞学样本,分为无CIN组152例、CIN1组147例和CIN2/3组148例,用qMSP分析15个基因的甲基化模式并在≤CIN1与CIN2+组间比较。

主要发现

  • 在验证集中,7个基因甲基化谱按诊断显著不同:DAPK1(p=0.001)、EPB41L3(p=0.001)、HIC1(p=0.028)、hsa-miR-124-2(p=0.001)、LMX1A(p=0.001)、SOX1(p=0.001)和TERT(p=0.001)。
  • 6个基因在hr-HPV存在时甲基化频率显著增加:DAPK1(p=0.001)、EPB41L3(p=0.001)、hsa-miR-124-2(p=0.001)、LMX1A(p=0.001)、SOX1(p=0.001)和TERT(p=0.001)。
  • hsa-miR-124基因甲基化的敏感度和特异度分别为86.7%和61.3%,与HPV检测的91.3%和50.0%相似。
  • 与CIN2+诊断独立相关的因素包括hr-HPV阳性(OR=5.5)以及hsa-miR-124-2(OR=5.1)、SOX1(OR=2.8)、TERT(OR=2.2)和LMX1A(OR=2.0)基因甲基化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The methylation profile of genes in precursor lesions in cervical cancer was characterized to improve screening techniques for high-grade intraepithelial neoplasia. METHODS: A total of 447 cervical cytology samples obtained from women who underwent colposcopy were examined. The cases were distributed as follows: (1) cervices without cervical intraepithelial neoplasia (CIN; n = 152); (2) cervices with a CIN grade of 1 (CIN 1; n = 147); and (3) cervices with a CIN grade of 2 or 3 (CIN 2/3; n = 148). The methylation pattern for a panel of 15 genes was analysed by quantitative methylation-specific PCR (qMSP) and compared between the groups (≤CIN 1 vs. CIN 2+). RESULTS: In the validation set, seven genes presented significantly different methylation profiles according to diagnosis, namely, DAPK1 (p = 0.001), EPB41L3 (p = 0.001), HIC1 (p = 0.028), hsa-miR-124-2 (p = 0.001), LMX1A (p = 0.001), SOX1 (p = 0.001), and TERT (p = 0.001). Six genes showed a significant increase in the frequency of methylation in the presence of hr-HPV, namely, DAPK1 (p = 0.001), EPB41L3 (p = 0.001), hsa-miR-124-2 (p = 0.001), LMX1A (p = 0.001), SOX1 (p = 0.001), and TERT (p = 0.001). The methylation of the hsa-miR-124 gene showed sensitivity and specificity (86.7% and 61.3%, respectively) similar to that of the HPV test (91.3% and 50.0%, respectively). The independent factors associated with the diagnosis of CIN 2+ and the methylation of the hsa-miR-124-2 (OR = 5.1), SOX1 (OR = 2.8), TERT (OR = 2.2), and LMX1A (OR = 2.0) genes were a positive test for hr-HPV (odds ratio [OR] = 5.5). CONCLUSIONS: Hypermethylation of the hsa-miR-124-2, SOX1, TERT, and LMX1A genes may be a promising biomarker for precursor lesions in cervical cancer regardless of the hr-HPV status.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Rogeri CD, Silveira HCS, Causin RL, et al. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer. Gynecol Oncol. 2018. PMID: 29960712. doi:10.1016/j.ygyno.2018.06.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。